[Coronary artery disease multivessel not amenable to revascularization: contemporary cohort]

Gustavo Inzunza-Cervantes1, Juan Ramón Herrera-Gavilanes1, Josué Abisai Félix-Córdova1

  • 1Instituto Mexicano del Seguro Social, Centro Médico Nacional del Noroeste, Hospital de Especialidades No. 2 "Luis Donaldo Colosio Murrieta", Grupo de Investigación Cardiovascular. Ciudad Obregón, Sonora, México.

Insights

Severe diffuse coronary artery disease not amenable to revascularization affects 12.2% of patients, predominantly older men with comorbidities. Despite challenges, contemporary prognosis is improving for this high-risk group.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Clinical Epidemiology

Background:

  • Severe diffuse coronary artery disease (CAD) unsuitable for revascularization is poorly understood, characterized by high morbidity, mortality, and reduced quality of life.
  • Limited contemporary research exists on the epidemiology, clinical presentation, and prognosis of this specific CAD subset.

Purpose of the Study:

  • To investigate the epidemiological, clinical, and prognostic aspects of three-vessel coronary artery disease not amenable to revascularization.
  • To address the knowledge gaps concerning this high-risk patient population.

Main Methods:

  • Retrospective observational cohort study.
  • Data collected from a National Medical Center.

Main Results:

  • Prevalence of three-vessel CAD not amenable to revascularization was 12.2%.
  • Patients were predominantly male (66%), over 65 years, with significant comorbidities.
  • Cardiovascular mortality was 9.4%; myocardial infarction occurred in 10.4%. Key mortality predictors included chronic kidney disease, age >70, and mitral valve insufficiency.

Conclusions:

  • Three-vessel coronary artery disease not amenable to revascularization remains a frequent clinical entity.
  • This patient group exhibits a high-risk clinical and anatomical profile.
  • Despite knowledge gaps, contemporary prognosis shows improvement for this condition.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
2.3K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
2
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
153
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2